Literature DB >> 16098625

Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.

Philippe Merle1, Miran Kim, Marc Herrmann, Anand Gupte, Lydie Lefrançois, Sophia Califano, Christian Trépo, Shinji Tanaka, Ludmila Vitvitski, Suzanne de la Monte, Jack R Wands.   

Abstract

BACKGROUND/AIMS: The molecular mechanisms of hepatocarcinogenesis remain largely unknown. Previous studies suggest that activation of the Wnt/beta-catenin pathway is important during hepatocyte transformation but the role of Frizzled receptor (FZD) in this process has not been defined. Here we investigate activation of this pathway by FZD using transgenic hepatocellular carcinoma (HCC) murine models.
METHODS: We employed single (c-myc, SV40-Tag) and established double [insulin receptor substrate-1 (IRS-1/c-myc) and hepatitis Bx protein (X/c-myc)] transgenic lines and all developed HCC. Expression of 9 FZD was measured by real time RT-PCR and Western blot analysis. Phosphorylation and cellular accumulation of beta-catenin were assessed in both dysplastic tissue and tumors. We investigated the effect of a dominant negative (DN) FZD7 on TCF transcriptional activity in a SV40 derived HCC cell line.
RESULTS: FZD7 was highly overexpressed at the mRNA and protein level(s) in HCC and occurred in dysplasia. Upregulation of FZD7 was associated with reduced phosphorylation of beta-catenin and led to nuclear accumulation in HCC tumors. Ectopic expression of a DN FZD7 construct decreased TCF transcriptional activity in tumor cells.
CONCLUSIONS: These observations suggest that upregulation of FZD7 receptors in association with activation of the canonical Wnt/beta-catenin pathway is a common molecular event in HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16098625     DOI: 10.1016/j.jhep.2005.05.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  71 in total

Review 1.  Genetics of hepatocellular carcinoma.

Authors:  Andreas Teufel; Frank Staib; Stephan Kanzler; Arndt Weinmann; Henning Schulze-Bergkamen; Peter-R Galle
Journal:  World J Gastroenterol       Date:  2007-04-28       Impact factor: 5.742

2.  MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7.

Authors:  Boya Deng; Yi Zhang; Siyang Zhang; Fang Wen; Yuan Miao; Kejun Guo
Journal:  Tumour Biol       Date:  2015-05-15

Review 3.  Chronic hepatitis B in hepatocarcinogenesis.

Authors:  N H Park; I H Song; Y-H Chung
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

4.  Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.

Authors:  Neung Hwa Park; Il Han Song; Young-Hwa Chung
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

5.  The WNT receptor FZD7 is required for maintenance of the pluripotent state in human embryonic stem cells.

Authors:  Antonio Fernandez; Ian J Huggins; Luca Perna; David Brafman; Desheng Lu; Shiyin Yao; Terry Gaasterland; Dennis A Carson; Karl Willert
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

6.  Hepatitis C virus induces epithelial-mesenchymal transition in primary human hepatocytes.

Authors:  Sandip K Bose; Keith Meyer; Adrian M Di Bisceglie; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

Review 7.  Wnt signaling in liver cancer.

Authors:  Yutaka Takigawa; Anthony M C Brown
Journal:  Curr Drug Targets       Date:  2008-11       Impact factor: 3.465

8.  Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.

Authors:  Haluk Yuzugullu; Khemais Benhaj; Nuri Ozturk; Serif Senturk; Emine Celik; Asli Toylu; Nilgun Tasdemir; Mustafa Yilmaz; Esra Erdal; Kamil Can Akcali; Nese Atabey; Mehmet Ozturk
Journal:  Mol Cancer       Date:  2009-10-22       Impact factor: 27.401

9.  Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells.

Authors:  Wei Wei; Mei-Sze Chua; Susan Grepper; Samuel K So
Journal:  Mol Cancer       Date:  2009-09-24       Impact factor: 27.401

10.  Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting.

Authors:  Grace E Snow; Allison C Kasper; Alexander M Busch; Elisabeth Schwarz; Katherine E Ewings; Thomas Bee; Michael J Spinella; Ethan Dmitrovsky; Sarah J Freemantle
Journal:  BMC Cancer       Date:  2009-10-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.